Kronos Worldwide (NYSE:KRO – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday.
Kronos Worldwide Stock Down 5.9 %
NYSE KRO traded down $0.47 during mid-day trading on Monday, reaching $7.40. 307,078 shares of the company’s stock traded hands, compared to its average volume of 197,173. Kronos Worldwide has a 1-year low of $7.33 and a 1-year high of $14.50. The company has a fifty day simple moving average of $9.21 and a 200-day simple moving average of $10.56. The company has a current ratio of 2.68, a quick ratio of 1.30 and a debt-to-equity ratio of 0.56. The company has a market cap of $850.69 million, a price-to-earnings ratio of 9.13 and a beta of 1.16.
Kronos Worldwide (NYSE:KRO – Get Free Report) last released its earnings results on Thursday, March 6th. The specialty chemicals company reported ($0.12) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.31). The firm had revenue of $423.10 million for the quarter, compared to the consensus estimate of $494.19 million. Kronos Worldwide had a return on equity of 11.74% and a net margin of 5.05%.
Institutional Trading of Kronos Worldwide
About Kronos Worldwide
Kronos Worldwide, Inc produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. The company produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics.
Featured Articles
- Five stocks we like better than Kronos Worldwide
- The Risks of Owning Bonds
- How to Protect Your Portfolio When Inflation Is Rising
- Upcoming IPO Stock Lockup Period, Explained
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Investing in Commodities: What Are They? How to Invest in Them
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Kronos Worldwide Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kronos Worldwide and related companies with MarketBeat.com's FREE daily email newsletter.